Wednesday, 24 May 2017

China News

  • Fortis sells its Singapore hospital

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Fortis Healthcare has sold its Singapore Hospital to Concord Medical Services for $40 million (Rs 251 crore) in line with the strategy to focus on the domestic market. "The Boar...Read more

  • China plans to slap 'astronomical' fines on GSK

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: In a bid to send out a strong statement, the Public Security Ministry in China has said on its official website that the country should learn from the practice of other nations a...Read more

  • Matt Kerr: Tough task ahead for APAC HR managers

    China |  Opinion | By BioSpectrum Bureau | 0 Comment

    With rapid growth of life sciences industry in Asia, we have seen many success stories over the last decade. However, any period of extensive growth is often accompanied by growing pains, p...Read more

  • BeiGene to build its first cGMP facility in Suzhou BioBAY

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: China's BeiGene, a clinical-stage biopharmaceutical company focused on developing molecularly-targeted and immuno-oncology drugs for the treatment of cancer, recently announced t...Read more

  • TaiGen initiates clinical trial of leukemia drug in China

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Taiwan's TaiGen Biotechnology has initiated first burixafor trial for relapsed or refractory acute myeloid leukemia in China. Burixafor is being studied in combination with two ...Read more

  • China approves Bayer's Xarelto

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Bayer's anticoagulant drug, Xarelto (rivaroxaban), has been approved by the China Food and Drug Administration (CFDA) for the prevention of stroke and systemic embolism in adult ...Read more

  • Genovate biotech to invest $1bn in China

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Genovate Biotechnology, Taiwan based pharmaceutical company, has started the construction of phase I of its Insulin Ecological Industrial Park in Changzhou National Hi-tech Distr...Read more

  • Innovation is the key driver

    China |  Analysis | By BioSpectrum Bureau | 0 Comment

    Singapore:  CHINA NATIONAL ACCORD MEDICINES, ChinaChairman: Mr Yan ZhigangRevenue: $3746.3mnBusiness: Engaged in wholesale and retail and research, development and production of pharmaceu...Read more

  • Mercury fever thermometers to phase out by 2020

    China |  Regulatory | By BioSpectrum Bureau | 0 Comment

    Singapore: WHO and Health Care without Harm, a non-governmental organization, have taken a new initiative to get mercury removed from all medical measuring devices by 2020. The initiative...Read more

  • GSK fires 100 Chinese employees over corruption charges

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: To clean up its act in China, GSK has further fired nearly 100 employees for misconduct and violation of GSK's governance and compliance procedures, a leading Chinese daily repor...Read more

  • American Chemical Society accolades WuXi member

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Dr Joseph Vacca, senior VP, Early Success Sharing Partnerships (ESSP), WuXi PharmaTech, a leading R&D outsourcing company serving the pharmaceutical, biotechnology and medica...Read more

  • DKSH obtains packaging license in Hong Kong

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Hong Kong-based DKSH, a provider of market expansion services, has obtained "License for Manufacturer (secondary packaging)" and the "License to Manufacture Preparations of Dange...Read more

  • Chinese Ebola vaccine found effective in human trials

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: An experimental Ebola vaccine candidate developed by the Beijing Institute of Biotechnology and the Tianjin CanSino Biotechnology has been found to be safe in phase I clinical tr...Read more

  • Catalent enters in multiple JVs in China

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Catalent Pharma Solutions announced two joint ventures in China for its Softgel Technologies and Clinical Supply Solutions businesses. Catalent continues to expand its global lea...Read more

  • Law firm investigates claims on behalf of Tibet Pharma investors

    China |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Pomerantz Haudek Grossman & Gross LLP is investigating claims on behalf of investors of Tibet Pharmaceuticals. It has been alleged that the specialty pharmaceutical company m...Read more

  • Market cap in APAC touches $200 bn

    China |  Analysis | By Narayan Kulkarni | 0 Comment

    About 500 bioscience companies comprising pharmaceutical, biotechnology and medical technology companies listed on different stock exchanges in Asia Pacific (APAC) region and in American st...Read more

  • China's CSPC Pharma has a rich product pipeline

    China |  Analysis | By BioSpectrum Bureau | 0 Comment

    Singapore:  CSPC PHARMACEUTICAL GROUP, China Chairman: Mr CAI DongchenRevenue: $1358.3 mnBusiness: Manufacturers of generics, bulk drug, innovative drugs  In 2014, CSPC Pharmaceutical c...Read more

  • A need to revive performance for this Chinese pharma company

    China |  Analysis | By BioSpectrum Bureau | 0 Comment

    Singapore:  CHINA RESOURCES SANJIU MEDICAL & PHARMACEUTICAL, China Chairman: Mr Li FuzuoRevenue: $1138mnBusiness: Engaged in research, development and production of pharmaceuticals an...Read more

Survey Box

Will biobanking change healthcare in the world?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls